| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director
4 companies
Boudreaux Gail serves as a Director at NVAX and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 9 buys and 6 sells. Those positions are worth an estimated $62.8M at current prices.
The biggest single holding is ELV (~$62.3M) as President And CEO. The recent filings there lean toward selling, a net 15,175 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | ELV Elevance Health, Inc. | President And CEO | Buy | 2,725 | $367.79 | $1,002,230.05 | +1.6% | +14.8% | - | |
| Jul 18, 2025 | ELV Elevance Health, Inc. | President And CEO | Buy | 8,500 | $286.94 | $2,438,951.30 | +6.0% | +25.7% | +34.7% | |
| Jul 22, 2024 | ELV Elevance Health, Inc. | President And CEO | Sell | 34,000 | $500.98 | $17,033,394.84 | -21.2% | -16.2% | -44.1% | |
| Jan 30, 2020 | ELV Elevance Health, Inc. | President And CEO | Buy | 7,600 | $263.70 | $2,004,152.00 | +40.1% | - | - | |
| Feb 5, 2019 | ZBH Zimmer Biomet Holdings, Inc. | Director | Buy | 2,095 | $119.33 | $249,987.97 | New | - | - | |
| Sep 20, 2016 | NVAX Novavax Inc | Director | Buy | 100,000 | $1.45 | $144,850.00 | +100.0% | - | - |